CURRENT PERSPECTIVE OF THERAPIES TO GLIOMAS EXPRESSING HEPATOCYTE GROWTH FACTOR

This paper present about Glioblastma multiforme (GBM) is the most common malignant brain tumor of the central nervous system (CNS), the purpose is to investigate the scatter factor/hepatocyte growth factor (SF/HGF) and other current perspective therapies involved in the therapeutic interventions of CNS tumours which would provide excellent tumor control and regression, and may improve the prognosis and quality of life of patients with neurological tumours.